Unique ID issued by UMIN | UMIN000032188 |
---|---|
Receipt number | R000036716 |
Scientific Title | Short-term effect of positive airway pressure therapy in patients with atrial fibrillation and sleep-disordered breathing |
Date of disclosure of the study information | 2018/04/11 |
Last modified on | 2019/10/14 10:27:18 |
Short-term effect of positive airway pressure therapy in patients with atrial fibrillation and sleep-disordered breathing
Short-term effect of positive airway pressure therapy in patients with atrial fibrillation and sleep-disordered breathing
Short-term effect of positive airway pressure therapy in patients with atrial fibrillation and sleep-disordered breathing
Short-term effect of positive airway pressure therapy in patients with atrial fibrillation and sleep-disordered breathing
Japan |
Atrial fibrillation, heart failure, sleep disordered breathing
Cardiology |
Others
NO
To investigate whether alleviation of sleep disordered breathing by positive airway pressure therapy can improve LV diastolic dysfunction and suppress sympathetic nerve activation
Efficacy
Change in E/e' by echocardiogram during 6 months and change in the H/M ratio and the wash out rate of 123I-MIBG during 6 months
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
No treatment
2
Treatment
Device,equipment |
Intervention group with positive airway pressure therapy (Continuous positive pressure therapy: CPAP and Adaptive servo ventilation: ASV) for 6 months
Control group with OMT (optimal medical therapy) for 6 months
20 | years-old | <= |
Not applicable |
Male and Female
1) Patients with AF (paroxysmal, persistent, and permanent)
2) Moderate to severe SDB (AHI is greater than or equal to 15 by home polygraphy test)
3) LV diastolic dysfunction (E/e' is greater than or equal to 15 by tissue Doppler echocardiogram)
1) LV systolic dysfunction (LV ejection fraction is less than or equal to 45% on echocardiogram)
2) Severe organic valvular diseases
3) Patients who have acute myocardial infarction, ICD or CRT device implantation, cardiac surgery including PCI and transcatheter aortic valve intervention during the 3 months preceding randomization.
4) Patients who have a possibility for pacemaker, ICD or CRT device implantation or cardiac or non-cardiac surgery including percutaneous coronary intervention, transcatheter aortic valve intervention in 3 months
5) Life-threatening diseases (uncured malignancy, severe chronic pulmonary diseases with oxygen inhalation or specific medication, and end stage renal disease with dialysis)
6) Patients who have already been initiated into PAP therapy
7) Pregnancy
60
1st name | |
Middle name | |
Last name | Takatoshi Kasai |
Juntendo University Graduate School of Medicine
Cardiovascular Respiratory Sleep Medicine
2-1-1 Hongo, Buryo-Ku, Tokyo
03-3813-3111
kasai-t@mx6.nisiq.net
1st name | |
Middle name | |
Last name | Takatoshi Kasai |
Juntendo University Graduate School of Medicine
Cardiovascular Respiratory Sleep Medicine
2-1-1 Hongo, Buryo-Ku, Tokyo
03-3813-3111
kasai-t@mx6.nisiq.net
Juntendo University Graduate School of Medicine
Cardiovascular Respiratory Sleep Medicine
Resmed Japan
Profit organization
NO
2018 | Year | 04 | Month | 11 | Day |
Unpublished
Terminated
2018 | Year | 03 | Month | 23 | Day |
2018 | Year | 03 | Month | 23 | Day |
2018 | Year | 04 | Month | 01 | Day |
2019 | Year | 03 | Month | 31 | Day |
2018 | Year | 04 | Month | 10 | Day |
2019 | Year | 10 | Month | 14 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036716